Aberrant changes of dynamic global synchronization in patients with Parkinson's disease

Abstract

Background Patients with Parkinson's disease (PD) have been documented with disrupted dynamic profiles of functional connectivity. However, the complementary information that is relevant to the dynamic pattern of global synchronization in patients with PD requires further investigation. Purpose To reveal the aberrant dynamic profiles of global synchronization involved in PD with a focus on temporal variability, strength, and property. Material and Methods A total of 46 patients with PD and 50 matched healthy controls (HCs) were enrolled. Degree centrality (DC) was used as the metric of global synchronization. The intergroup differences in the dynamic DC (dDC) pattern were compared, followed by further analysis of their clinical relevance in PD. Results Relative to HCs, the PD group showed decreased dDC variability in right inferior occipital gyrus, right insula, right middle occipital gyrus (MOG), and bilateral postcentral gyrus. The dDC variability in the MOG was significantly correlated with MoCA score. Two states (state I and state II) were suggested. Relative to HCs, the PD group demonstrated a shorter mean dwell time (MDT) in state I, a longer MDT in state II, and fewer transitions. For the PD group, dDC properties were significantly correlated with UPDRS-III scores. In state II, significantly decreased dynamic dDC strength in bilateral supplementary motor area was observed in the PD group, with a significant correlation with UPDRS-III scores. Conclusion These findings on PD imply that dynamic alterations of global synchronization are engaged in the dysfunction of movement and cognition, deepening the understanding of deteriorations that underlie PD with complementary evidence.

Alteration of brain network centrality in CTN patients after a single triggering pain

“…Dynamic DC (dDC) is a method combines sDC with “sliding window” ( Tian et al, 2022 ), reflecting the time dynamics of remote functional connectivity ( Du et al, 2021 ). Although dDC has not been reported in TN, it has been applied to Parkinson’s disease ( Wang et al, 2022 ), major depressive disorder (MDD) ( Yang et al, 2022 ), schizophrenia ( Wang et al, 2021 ), depressive mania ( Sun et al, 2022 ), and other diseases.…”